Economic Evaluation of the Hepatitis C Virus Treatment Extension to Early-Stage Fibrosis Patients: Evidence from the PITER Real-World Cohort. [electronic resource]
Producer: 20180806Description: 783-791 p. digitalISSN:- 1524-4733
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antiviral Agents -- adverse effects
- Budgets
- Computer Simulation
- Cost-Benefit Analysis
- Drug Costs
- Drug Therapy, Combination
- Female
- Hepacivirus -- drug effects
- Hepatitis C, Chronic -- diagnosis
- Humans
- Italy -- epidemiology
- Liver Cirrhosis -- diagnosis
- Male
- Markov Chains
- Middle Aged
- Models, Economic
- Monte Carlo Method
- Multivariate Analysis
- Quality-Adjusted Life Years
- Registries
- Time Factors
- Treatment Outcome
- Uncertainty
- Young Adult
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.